Pharma Reviews: Icra sees pharma industry growth tapering to 7-10% over FY18-FY20

Mumbai: The Indian pharmaceutical industry is likely to witness a slowdown in growth over the next three years because of pricing pressure and ...
Read more: Icra sees pharma industry growth tapering to 7-10% over FY18-FY20